1. Home
  2. DH vs ELDN Comparison

DH vs ELDN Comparison

Compare DH & ELDN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Definitive Healthcare Corp.

DH

Definitive Healthcare Corp.

N/A

Current Price

$1.12

Market Cap

283.1M

Sector

Technology

ML Signal

N/A

Logo Eledon Pharmaceuticals Inc.

ELDN

Eledon Pharmaceuticals Inc.

N/A

Current Price

$2.92

Market Cap

229.3M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
DH
ELDN
Founded
2011
2004
Country
United States
United States
Employees
N/A
N/A
Industry
Computer Software: Prepackaged Software
Biotechnology: Pharmaceutical Preparations
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
283.1M
229.3M
IPO Year
2021
2014

Fundamental Metrics

Financial Performance
Metric
DH
ELDN
Price
$1.12
$2.92
Analyst Decision
Hold
Strong Buy
Analyst Count
5
2
Target Price
$3.43
$8.50
AVG Volume (30 Days)
392.1K
1.2M
Earning Date
05-07-2026
03-19-2026
Dividend Yield
N/A
N/A
EPS Growth
63.28
30.67
EPS
N/A
N/A
Revenue
$241,521,000.00
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
$0.30
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$0.97
$1.35
52 Week High
$4.70
$4.60

Technical Indicators

Market Signals
Indicator
DH
ELDN
Relative Strength Index (RSI) 35.39 57.93
Support Level $1.07 $2.48
Resistance Level $1.29 $3.15
Average True Range (ATR) 0.09 0.23
MACD 0.03 -0.00
Stochastic Oscillator 43.68 54.48

Price Performance

Historical Comparison
DH
ELDN

About DH Definitive Healthcare Corp.

Definitive Healthcare Corp is a provider of healthcare commercial intelligence. Its SaaS-based healthcare commercial intelligence platform is designed to provide comprehensive and accurate information on the healthcare ecosystem in the U.S. The platform uses deep analytics and data science to help customers develop data-driven strategic decisions, such as finding new markets to enter, building comprehensive go-to-market strategies, accessing tactical information to help target the right decision makers, and improving win rates with detailed contextual information. The company derives substantially all of its revenue from the sale of subscription fees for access to its platform and stand-ready support. Geographically, it derives a majority of its revenue from the United States.

About ELDN Eledon Pharmaceuticals Inc.

Eledon Pharmaceuticals Inc is a clinical-stage biotechnology company. The firm is focused on transplantation and autoimmune diseases. It targets the CD40L pathway to develop potential treatments for patients living with an autoimmune disease, patients requiring an organ or cell-based transplant, and patients living with ALS. The company's compound in development is tegoprubart, an IgG1, an anti-CD40L antibody with high affinity for the CD40 Ligand, a well-validated biological target that has broad therapeutic potential.

Share on Social Networks: